Get started
RocketTickers

BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA

Long
BeiGene, Ltd. (NASDAQ:BGNE)  
RocketTickers  
NASDAQ:BGNE   BeiGene, Ltd.
Beyond Technical Analysis
0
0
beyondta
BGNE: BeiGene, Ltd.
2021-07-29 20:00:00
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.